Potentiation of antibiofilm activity of amphotericin B by superoxide dismutase inhibition

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  De Brucker, Katrijn ^a   Bink, Anna ^a   Meert, Els ^a   Cammue, Bruno P A ^a,b   Thevissen, Karin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b CMPG   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM TETRATHIOMOLYBDATE; AMPHOTERICIN B; BIOFILM CELLS; CANDIDA ALBICANS; DIETHYLDITHIOCARBAMATE; REACTIVE OXYGEN SPECIES; SUPER OXIDE DISMUTASE; SUPEROXIDE DISMUTASES;

CANDIDA; OXYGEN;

BIOFILMS;

AMPHOTERICIN B; DIETHYLDITHIOCARBAMIC ACID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TETRATHIOMOLYBDATE AMMONIUM; MOLYBDENUM; TETRATHIOMOLYBDIC ACID;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; FUNGAL CELL; INTRACELLULAR SPACE; NONHUMAN; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; DRUG ANTAGONISM; DRUG EFFECT;

AMPHOTERICIN B; BIOFILMS; DITIOCARB; MOLYBDENUM; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84884848764     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/704654     Document Type: Article

References (30)

1. Ramage G., Mowat E., Jones B., Williams C., Lopez-Ribot J., Our current understanding of fungal biofilms fungal biofilms. Critical Reviews in Microbiology 2009 35 4 340 355 2-s2.0-70350557500 10.3109/10408410903241436
2. Mishra N. N., Prasad T., Sharma N., Payasi A., Prasad R., Gupta D. K., Singh R., Pathogenicity and drug resistance in Candida albicans and other yeast species. Acta Microbiologica et Immunologica Hungarica 2007 54 3 201 235 2-s2.0-34548429972 10.1556/AMicr.54.2007.3.1 (Pubitemid 47364462)
3. Seneviratne C. J., Jin L., Samaranayake L. P., Biofilm lifestyle of Candida: a mini review. Oral Diseases 2008 14 7 582 590 2-s2.0-53149143909 10.1111/j.1601-0825.2007.01424.x
4. Ramage G., Martínez J. P., López-Ribot J. L., Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Research 2006 6 7 979 986 2-s2.0-33749986341 10.1111/j.1567-1364.2006.00117.x (Pubitemid 44568854)
5. Cassone A., Fungal vaccines: real progress from real challenges. The Lancet Infectious Diseases 2008 8 2 114 124 2-s2.0-38349120520 10.1016/S1473-3099(08)70016-1
6. Didone L., Oga D., Krysan D. J., A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms. Yeast 2011 28 8 561 568 2-s2.0-79960978214 10.1002/yea.1860
7. Kuhn D. M., George T., Chandra J., Mukherjee P. K., Ghannoum M. A., Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrobial Agents and Chemotherapy 2002 46 6 1773 1780 2-s2.0-0036096359 10.1128/AAC.46.6.1773-1780.2002 (Pubitemid 34535196)
8. Shuford J. A., Rouse M. S., Piper K. E., Steckelberg J. M., Patel R., Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. The Journal of Infectious Diseases 2006 194 5 710 713 2-s2.0-33748035709 10.1086/506452 (Pubitemid 44297859)
9. Al-Dhaheri R. S., Douglas L. J., Apoptosis in Candida biofilms exposed to amphotericin B. Journal of Medical Microbiology 2010 59 2 149 157 2-s2.0-76049117463 10.1099/jmm.0.015784-0
10. Phillips A. J., Sudbery I., Ramsdale M., Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14327 14332 2-s2.0-0344630224 10.1073/pnas.2332326100 (Pubitemid 37499236)
11. Clemons K. V., Schwartz J. A., Stevens D. A., Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Medical Mycology 2011 49 8 834 847 2-s2.0-80054709751 10.3109/13693786.2011.577822
12. Patel G. P., Crank C. W., Leikin J. B., An evaluation of hepatotoxicity and nephrotoxicity of liposomal amphotericin B (L-AMB). Journal of Medical Toxicology 2011 7 1 12 15 2-s2.0-79952629143 10.1007/s13181-010-0120-8
13. Frohner I. E., Bourgeois C., Yatsyk K., Majer O., Kuchler K., Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Molecular Microbiology 2009 71 1 240 252 2-s2.0-58149136353 10.1111/j.1365-2958.2008.06528.x
14. Martchenko M., Alarco A.-M., Harcus D., Whiteway M., Superoxide dismutases in Candida albicans: transcriptional regulation and functional characterization of the hyphal-induced sod5 gene. Molecular Biology of the Cell 2004 15 2 456 467 2-s2.0-0742288065 10.1091/mbc.E03-03-0179 (Pubitemid 38146465)
15. Lushchak V., Semchyshyn H., Lushchak O., Mandryk S., Diethyldithiocarbamate inhibits in vivo Cu,Zn-superoxide dismutase and perturbs free radical processes in the yeast Saccharomyces cerevisiae cells. Biochemical and Biophysical Research Communications 2005 338 4 1739 1744 2-s2.0-27844572415 10.1016/j.bbrc.2005.10.147 (Pubitemid 41643084)
16. Bink A., Vandenbosch D., Coenye T., Nelis H., Cammue B. P. A., Thevissen K., Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole. Antimicrobial Agents and Chemotherapy 2011 55 9 4033 4037 2-s2.0-80051804445 10.1128/AAC.00280-11
17. Brewer G. J., Askari F., Dick R. B., Sitterly J., Fink J. K., Carlson M., Kluin K. J., Lorincz M. T., Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine. Translational Research 2009 154 2 70 77 2-s2.0-67649874760 10.1016/j.trsl.2009.05.002
18. Mills C. F., El-Gallad T. T., Bremner I., Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats. Journal of Inorganic Biochemistry 1981 14 3 189 207 2-s2.0-0019509705 10.1016/S0162-0134(00)80000-8 (Pubitemid 11063055)
19. Van Den Berghe P. V. E., Klomp L. W. J., New developments in the regulation of intestinal copper absorptionn. Nutrition Reviews 2009 67 11 658 672 2-s2.0-74949100486 10.1111/j.1753-4887.2009.00250.x
20. Chidambaram M. V., Barnes G., Frieden E., Inhibition of ceruloplasmin and other copper oxidases by thiomolybdate. Journal of Inorganic Biochemistry 1984 22 4 231 239 2-s2.0-0021712412 10.1016/0162-0134(84)85008-4 (Pubitemid 15155852)
21. Juarez J. C., Betancourt O. Jr., Pirie-Shepherd S. R., Guan X., Price M. L., Shaw D. E., Mazar A. P., Doñate F., Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clinical Cancer Research 2006 12 16 4974 4982 2-s2.0-33748340865 10.1158/1078-0432.CCR-06-0171 (Pubitemid 44338586)
22. Medici V., Sturniolo G. C., Tetrathiomolybdate, a copper chelator for the treatment of Wilson disease, pulmonary fibrosis and other indications. IDrugs 2008 11 8 592 606 2-s2.0-49249110986
23. LaFleur M. D., Qi Q., Lewis K., Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrobial Agents and Chemotherapy 2010 54 1 39 44 2-s2.0-73849102829 10.1128/AAC.00860-09
24. Viquez O. M., Valentine H. L., Amarnath K., Milatovic D., Valentine W. M., Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy. Toxicology and Applied Pharmacology 2008 229 1 77 85 2-s2.0-42749097263 10.1016/j.taap.2008.01. 005
25. Invitrogen, The molecular probes handbook, 11th edition, chapter 18, section 18. 2
26. Seneviratne C. J., Wang Y., Jin L., Abiko Y., Samaranayake L. P., Candida albicans biofilm formation is associated with increased anti-oxidative capacities. Proteomics 2008 8 14 2936 2947 2-s2.0-48949100522 10.1002/pmic.200701097
27. Kim J. H., Chan K. L., Mahoney N., Campbell B. C., Antifungal activity of redox-active benzaldehydes that target cellular antioxidation. Annals of Clinical Microbiology and Antimicrobials 2011 10, article 23 2-s2.0-79957639708 10.1186/1476-0711-10-23
28. Kim J. H., Faria N. C., Martins M. L., Chan K. L., Campbell B. C., Enhancement of antimycotic activity of amphotericin B by targeting the oxidative stress response of Candida and Cryptococcus with natural dihydroxybenzaldehydes. Frontiers in Microbiology 2012 3 261
29. Kim J. H., Chan K. L., Faria N. C., Martins M. L., Campbell B. C., Targeting the oxidative stress response system of fungi with redox-potent chemosensitizing agents. Frontiers in Microbiology 2012 3 88
30. Walker E. M. Jr., Cannon D. J., Reifsteck M. E., Effects of diethyldithiocarbamate and structural analogs in mice with systemic candidial infections. Research Communications in Chemical Pathology and Pharmacology 1987 56 2 253 263 2-s2.0-0023258562 (Pubitemid 17082462)